{"id":{"repo_id":"emich","oai_identifier":"oai:commons.emich.edu:theses-2469"},"canonical_url":"https://search.dev.ndltd.org/etd/emich/oai:commons.emich.edu:theses-2469","repository":{"repo_id":"emich","name":"Eastern Michigan University","base_url":"https://commons.emich.edu/do/oai/"},"display":{"title":"Demographic characteristics of the COVID-19 vaccine trial participant population, mortality population, and individuals fully vaccinated in the United States: A comparative analysis","abstract":"<p>The purpose of this study was to compare the demographic variables of three populations, COVID-19 vaccine trial participants, COVID-19 deaths, and individuals vaccinated for COVID-19, to determine if the trial participants were appropriately representative. Demographic data (age, sex, race and ethnicity, and presence of comorbidities) were collected from publicly available datasets, organized, and compared. The demographic characteristics of the vaccine clinical trials participants were comparable to those who died due to COVID-19, but less comparable to those who were the first to receive a COVID-19 emergency-use-authorized vaccine.</p>","abstract_html":"&lt;p&gt;The purpose of this study was to compare the demographic variables of three populations, COVID-19 vaccine trial participants, COVID-19 deaths, and individuals vaccinated for COVID-19, to determine if the trial participants were appropriately representative. Demographic data (age, sex, race and ethnicity, and presence of comorbidities) were collected from publicly available datasets, organized, and compared. The demographic characteristics of the vaccine clinical trials participants were comparable to those who died due to COVID-19, but less comparable to those who were the first to receive a COVID-19 emergency-use-authorized vaccine.&lt;/p&gt;","abstract_has_math":false,"creators":["Walters, Lisa"],"institution":null,"degree_name":"Master of Science (MS)","degree_level":"Open Access Thesis","degree_discipline":"Health Sciences","degree_department":null,"school":null,"contributors":["Jean Rowan, MD, MS, Chair","Michael Switzer, PhD"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2021,"date_issued":"2021-01-01T08:00:00Z","date_published":"2021-01-01T08:00:00Z","updated_at":"2026-07-24T02:17:40Z","subjects":["Medicine and Health Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://commons.emich.edu/theses/1083","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Jean Rowan, MD, MS, Chair","Michael Switzer, PhD"]},{"key":"dc:creator","label":"Author","values":["Walters, Lisa"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2021-10-13T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Health Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Open Access Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (MS)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medicine and Health Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://commons.emich.edu/theses/1083"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>The purpose of this study was to compare the demographic variables of three populations, COVID-19 vaccine trial participants, COVID-19 deaths, and individuals vaccinated for COVID-19, to determine if the trial participants were appropriately representative. Demographic data (age, sex, race and ethnicity, and presence of comorbidities) were collected from publicly available datasets, organized, and compared. The demographic characteristics of the vaccine clinical trials participants were comparable to those who died due to COVID-19, but less comparable to those who were the first to receive a COVID-19 emergency-use-authorized vaccine.</p>"]},{"key":"dc:title","label":"Title","values":["Demographic characteristics of the COVID-19 vaccine trial participant population, mortality population, and individuals fully vaccinated in the United States: A comparative analysis"]}]}],"canonical_facts":{"dc:contributor":["Jean Rowan, MD, MS, Chair","Michael Switzer, PhD"],"dc:creator":["Walters, Lisa"],"dc:date.available":["2021-10-13T07:00:00Z"],"dc:description.abstract":["<p>The purpose of this study was to compare the demographic variables of three populations, COVID-19 vaccine trial participants, COVID-19 deaths, and individuals vaccinated for COVID-19, to determine if the trial participants were appropriately representative. Demographic data (age, sex, race and ethnicity, and presence of comorbidities) were collected from publicly available datasets, organized, and compared. The demographic characteristics of the vaccine clinical trials participants were comparable to those who died due to COVID-19, but less comparable to those who were the first to receive a COVID-19 emergency-use-authorized vaccine.</p>"],"dc:identifier":["https://commons.emich.edu/theses/1083"],"dc:subject":["Medicine and Health Sciences"],"dc:title":["Demographic characteristics of the COVID-19 vaccine trial participant population, mortality population, and individuals fully vaccinated in the United States: A comparative analysis"],"thesis:degree_discipline":["Health Sciences"],"thesis:degree_level":["Open Access Thesis"],"thesis:degree_name":["Master of Science (MS)"]},"updated_at":"2026-07-24T02:17:40Z"}